Neuropsychopharmacology in the era of artificial intelligence and biomolecule prediction software
Abstract The development and adoption of artificial intelligence (AI) provides moonshot opportunities to redefine how we generate treatments for neuropsychiatric disease. Despite the rapid advancement of AI across biomedical spheres, its implementation in drug discovery, proteomics, and neurobiology...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer
2025-06-01
|
| Series: | NPP-Digital Psychiatry and Neuroscience |
| Online Access: | https://doi.org/10.1038/s44277-025-00038-9 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|